Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 3
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Euthanimal 20% 200 mg/ml V/MRP/13/0027 Alfasan Nederland BV, Nīderlande QN51AA01 tortoises; guinea pigs; hamsters; cattle; pigs; sheep; goats; horses; mouses; rats; dogs; cats; rabbits; pigeons; ducks; chickens; exotic birds; snakes; lizards; frogs Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Pentobarbital Sodium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande
Date of authorisation/renewal: 28-Nov-2017
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (28-Aug-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (28-Aug-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (28-Aug-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/13/0027-01 200 mg/ml 12 Stikla flakons, 100 ml -
V/MRP/13/0027-02 200 mg/ml 6 Stikla flakons, 250 ml -
V/MRP/13/0027-03 200 mg/ml 1 Stikla flakons, 100 ml -
V/MRP/13/0027-04 200 mg/ml 1 Stikla flakons, 250 ml -
Euthanimal 40% 400 mg/ml V/MRP/13/0028 Alfasan Nederland BV, Nīderlande QN51AA01 tortoises; guinea pigs; hamsters; cattle; pigs; sheep; goats; horses; mouses; rats; dogs; cats; rabbits; pigeons; ducks; chickens; exotic birds; snakes; lizards; frogs Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Pentobarbital Sodium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande
Date of authorisation/renewal: 28-Nov-2017
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (28-Aug-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (28-Aug-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (28-Aug-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/13/0028-01 400 mg/ml 12 Stikla flakons, 100 ml -
V/MRP/13/0028-02 400 mg/ml 6 Stikla flakons, 250 ml -
V/MRP/13/0028-03 400 mg/ml 1 Stikla flakons, 100 ml -
V/MRP/13/0028-04 400 mg/ml 1 Stikla flakons, 250 ml [JPG]
Cazitel Plus XL - V/MRP/12/0060 Chanelle Pharmaceuticals Manufacturing Ltd., Īrija QP52AA51 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Febantel,Praziquantel,Pyrantel embonate
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
Date of authorisation/renewal: 31-Jul-2017
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (30-May-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (30-May-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (18-Jul-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/12/0060-01 2 PVH/PE/PHTFE/alumīnija blisteris, 1 tablete -
V/MRP/12/0060-02 4 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-03 5 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-04 6 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-05 8 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-06 10 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-07 12 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-08 14 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-09 16 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-10 18 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-11 20 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-12 24 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-13 28 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-14 30 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-15 32 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-16 36 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-17 40 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-18 42 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-19 44 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-20 48 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-21 50 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-22 52 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-23 56 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-24 60 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-25 64 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-26 68 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-27 70 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-28 72 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-29 76 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-30 80 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-31 84 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-32 88 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-33 92 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-34 96 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-35 98 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-36 100 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-37 104 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-38 106 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-39 108 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-40 112 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-41 116 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-42 120 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-43 140 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-44 150 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-45 180 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-46 200 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-47 204 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-48 206 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-49 208 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-50 250 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-51 280 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-52 300 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-53 500 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-54 1000 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
Prazitel Plus - V/MRP/09/0027 Chanelle Pharmaceuticals Manufacturing Ltd., Īrija QP52AA51 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Praziquantel, Pyrantel embonate, Febantel
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
Date of authorisation/renewal: 08-Apr-2014
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (14-Jun-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (14-Jun-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (18-Jul-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/09/0027-01 2 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-02 4 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-03 6 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-04 8 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-05 10 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-06 12 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-07 14 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-08 16 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-09 18 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-10 20 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-11 24 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-12 28 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-13 30 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-14 32 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-15 36 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-16 40 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-17 42 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-18 44 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-19 48 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-20 50 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-21 52 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-22 56 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-23 60 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-24 70 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-25 80 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-26 84 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-27 90 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-28 98 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-29 100 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-30 104 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-31 106 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-32 120 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-33 140 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-34 150 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-35 180 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-36 200 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-37 204 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-38 206 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-39 250 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-40 280 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-41 300 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-42 500 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-43 1000 Alumīnija blisteris, 1 tablete -
Fugasol 10 mg/ml V/DCP/22/0042 CP-Pharma Handelsgesellschaft GmbH, Vācija QJ02AC02 cats Vairāk

Medicinal product information

Pharmaceutical form: Oral solution
International name (active substance): Itraconazole
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release CP-Pharma Handelsgesellschaft GmbH, Vācija
Date of authorisation/renewal: 27-Oct-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Apr-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Apr-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-Apr-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/22/0042-01 10 mg/ml 1 Stikla pudele (dzintarkrāsas), 25 ml -
V/DCP/22/0042-02 10 mg/ml 1 Stikla pudele (dzintarkrāsas), 50 ml -
V/DCP/22/0042-03 10 mg/ml 1 Stikla pudele (dzintarkrāsas), 100 ml -
V/DCP/22/0042-04 10 mg/ml 1 ABPE pudele, 25 ml -
V/DCP/22/0042-05 10 mg/ml 1 ABPE pudele, 50 ml -
V/DCP/22/0042-06 10 mg/ml 1 ABPE pudele, 100 ml -
Dehinel Plus Flavour - V/DCP/11/0002 KRKA, d.d., Novo mesto, Slovēnija QP52AA30 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Febantel,Praziquantel,Pyrantel embonate
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 29-Dec-2015
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Nov-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Nov-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (22-Nov-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/11/0002-01 1 Alumīnija blisteris, 2 tablete [PDF] [PDF]
V/DCP/11/0002-02 2 Alumīnija blisteris, 2 tablete [JPG]
V/DCP/11/0002-03 1 Alumīnija blisteris, 10 tablete [PDF]
V/DCP/11/0002-04 3 Alumīnija blisteris, 10 tablete -
V/DCP/11/0002-05 5 Alumīnija blisteris, 10 tablete -
V/DCP/11/0002-06 10 Alumīnija blisteris, 10 tablete [PDF] [PDF]
V/DCP/11/0002-07 30 Alumīnija blisteris, 10 tablete -
Dehinel Plus XL - V/DCP/11/0003 KRKA, d.d., Novo mesto, Slovēnija QP52AA30 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Febantel, Pyrantel embonate, Praziquantel
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija;Virbac S.A., Francija;KRKA-Farma d.o.o., Horvātija
Date of authorisation/renewal: 29-Dec-2015
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Nov-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Nov-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (22-Nov-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/11/0003-01 1 Alumīnija blisteris, 2 tablete [PDF] [PDF]
V/DCP/11/0003-02 2 Alumīnija blisteris, 2 tablete -
V/DCP/11/0003-03 1 Alumīnija blisteris, 10 tablete -
V/DCP/11/0003-04 2 Alumīnija blisteris, 6 tablete [JPG] [JPG]
V/DCP/11/0003-05 4 Alumīnija blisteris, 6 tablete -
V/DCP/11/0003-06 3 Alumīnija blisteris, 10 tablete -
V/DCP/11/0003-07 5 Alumīnija blisteris, 6 tablete -
V/DCP/11/0003-08 10 Alumīnija blisteris, 6 tablete [JPG] [JPG]
V/DCP/11/0003-09 6 Alumīnija blisteris, 10 tablete [JPG] [JPG]
V/DCP/11/0003-10 10 Alumīnija blisteris, 10 tablete [JPG] [JPG]
V/DCP/11/0003-11 17 Alumīnija blisteris, 6 tablete -
V/DCP/11/0003-12 5 Alumīnija blisteris, 10 tablete [JPG]
Porcilis Ery+Parvo - V/NRP/96/0378 Intervet International B.V., Nīderlande QI09AL01 pigs Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Inactivated porcine parvovirus,Inactivated Erysipelothrix rhusiopathiae
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International B.V., Nīderlande
Date of authorisation/renewal: 15-Oct-2010
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Jan-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Jan-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (24-Jan-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/96/0378-01 1 Flakons, 10 deva -
V/NRP/96/0378-02 1 Flakons, 25 deva -
V/NRP/96/0378-03 1 Flakons, 50 deva -
V/NRP/96/0378-04 1 Flakons, 125 deva -
BIOSUIS APP 2,9,11 - V/MRP/14/0002 Bioveta, a.s., Čehija QI09AB07 pigs Vairāk

Medicinal product information

Pharmaceutical form: emulsion for injection
International name (active substance): Actinobacillus pleuropneumoniae serotype 2,Actinobacillus pleuropneumoniae serotype 9,11,Toxoid APX I,Toxoid APX II,Toxoid APX III
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 30-Mar-2017
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (26-Mar-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (26-Mar-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (26-Mar-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/14/0002-01 1 Stikla flakons, 50 deva -
V/MRP/14/0002-02 1 Stikla flakons, 100 deva -
V/MRP/14/0002-03 1 Plastikāta pudelīte, 10 deva -
V/MRP/14/0002-04 1 Plastikāta pudelīte, 50 deva -
V/MRP/14/0002-05 1 Plastikāta pudelīte, 100 deva -
V/MRP/14/0002-06 1 Plastikāta pudelīte, 250 deva -
V/MRP/14/0002-07 1 Stikla flakons, 10 deva -
V/MRP/14/0002-08 10 Stikla flakons, 10 deva -
V/MRP/14/0002-09 10 Plastikāta pudelīte, 10 deva -
V/MRP/14/0002-10 10 Stikla flakons, 10 deva -
V/MRP/14/0002-11 10 Plastikāta pudelīte, 10 deva -
AviPro ND C131 - V/MRP/08/1562 Lohmann Animal Health GmbH , Vācija QI01AD06 turkeys; chickens Vairāk

Medicinal product information

Pharmaceutical form: lyophilizate for suspension
International name (active substance): Newcastle disease virus, Clone 13-1
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lohmann Animal Health GmbH , Vācija
Date of authorisation/renewal: 24-Feb-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (30-Nov-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (30-Nov-2023)
Summary of product characteristics: [DOC] Zāļu_informācija_ZA_M_LI (30-Nov-2023)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/08/1562-04 10 Stikla flakons, 5000 deva -
V/MRP/08/1562-09 1 Stikla flakons, 5000 deva -
V/MRP/08/1562-11 1 Stikla flakons, 2000 deva -
V/MRP/08/1562-12 10 Stikla flakons, 2000 deva -
Zodon 25 mg/ml V/MRP/18/0043 Ceva Sante Animale', Francija QJ01FF01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for oral use
International name (active substance): Clindamycin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release CEVA SANTE ANIMALE., Francija
Date of authorisation/renewal: 27-Feb-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Jul-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Jul-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (23-Jul-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/18/0043-01 1 Stikla flakons, 20 ml -
EVOCTIN 10 mg/ml V/DCP/24/0069 Adoh B.V., Nīderlande QP54AA01 cattle; pigs; sheep Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Ivermectin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Pasteur Filiala Pilipesti S.A., Rumānija
Date of authorisation/renewal: 28-Oct-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (28-Oct-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (28-Oct-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (28-Oct-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0069-01 1 Stikla pudele, 50 ml -
V/DCP/24/0069-02 1 Stikla pudele, 100 ml -
V/DCP/24/0069-03 1 Stikla pudele, 250 ml -
V/DCP/24/0069-04 1 Stikla pudele, 500 ml -
TAbic IB VAR - V/MRP/14/0067 PHIBRO ANIMAL HEALTH (POLAND) Sp. z o.o., Polija QI01AA03 chickens Vairāk

Medicinal product information

Pharmaceutical form: Effervescent tablet
International name (active substance): Live attenuated Avian Infectious Bronchitis Virus, strain 233A
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Synoptis Industrial Sp. z o.o., Polija
Date of authorisation/renewal: 02-Aug-2016
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (11-Jun-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (11-Jun-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (11-Jun-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/14/0067-01 1 Al/Al blisteris, 1000 deva -
V/MRP/14/0067-02 1 Al/Al blisteris, 2000 deva -
V/MRP/14/0067-03 1 Al/Al blisteris, 2500 deva -
V/MRP/14/0067-04 1 Al/Al blisteris, 5000 deva -
V/MRP/14/0067-05 1 Al/Al blisteris, 10000 deva -
Selehold 45 mg V/DCP/18/0066 KRKA, d.d., Novo mesto, Slovēnija QP54AA05 cats 2,6 - 7,5 kg Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Selamectin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija;TAD Pharma GmbH, Vācija
Date of authorisation/renewal: 04-Dec-2018
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Dec-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Dec-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (20-Dec-2023)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/18/0066-01 1 Polipropilēna pipete, 0,75 ml/deva -
V/DCP/18/0066-02 3 Polipropilēna pipete, 0,75 ml/deva -
V/DCP/18/0066-03 6 Polipropilēna pipete, 0,75 ml/deva -
V/DCP/18/0066-04 15 Polipropilēna pipete, 0,75 ml/deva -
Rimadyl Palatable Tablets 20 mg V/NRP/02/1454 Zoetis Belgium S.A., Beļģija QM01AE91 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Carprofen
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Zoetis Belgium S.A., Beļģija
Date of authorisation/renewal: 05-Jul-2012
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Sep-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Sep-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (22-Sep-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/02/1454-01 20 mg 14 Blisteris, 1 tablete -
V/NRP/02/1454-02 20 mg 20 Polietilēna pudelīte, 1 tablete -
V/NRP/02/1454-03 20 mg 30 Polietilēna pudelīte, 1 tablete -
V/NRP/02/1454-04 20 mg 50 Polietilēna pudelīte, 1 tablete -
V/NRP/02/1454-05 20 mg 60 Polietilēna pudelīte, 1 tablete -
V/NRP/02/1454-06 20 mg 100 Polietilēna pudelīte, 1 tablete -
V/NRP/02/1454-07 20 mg 180 Polietilēna pudelīte, 1 tablete -
Rimadyl Palatable Tablets 50 mg V/NRP/07/1683 Zoetis Belgium S.A., Beļģija QM01AE91 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Carprofen
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Zoetis Belgium S.A., Beļģija
Date of authorisation/renewal: 05-Jul-2012
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Sep-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Sep-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (22-Sep-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/07/1683-01 50 mg 14 Polietilēna pudelīte, 1 tablete -
V/NRP/07/1683-02 50 mg 20 Polietilēna pudelīte, 1 tablete -
V/NRP/07/1683-03 50 mg 30 Polietilēna pudelīte, 1 tablete -
V/NRP/07/1683-04 50 mg 50 Polietilēna pudelīte, 1 tablete -
V/NRP/07/1683-05 50 mg 60 Polietilēna pudelīte, 1 tablete -
V/NRP/07/1683-06 50 mg 100 Polietilēna pudelīte, 1 tablete -
V/NRP/07/1683-07 50 mg 180 Polietilēna pudelīte, 1 tablete -
Rimadyl Palatable Tablets 100 mg V/NRP/07/1686 Zoetis Belgium S.A., Beļģija QM01AE91 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Carprofen
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Zoetis Belgium S.A., Beļģija
Date of authorisation/renewal: 05-Jul-2012
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Sep-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Sep-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (22-Sep-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/07/1686-01 100 mg 14 Polietilēna pudele, 1 tablete -
V/NRP/07/1686-02 100 mg 20 Polietilēna pudelīte, 1 tablete -
V/NRP/07/1686-03 100 mg 30 Polietilēna pudelīte, 1 tablete -
V/NRP/07/1686-04 100 mg 50 Polietilēna pudelīte, 1 tablete -
V/NRP/07/1686-05 100 mg 60 Polietilēna pudelīte, 1 tablete -
V/NRP/07/1686-06 100 mg 100 Polietilēna pudelīte, 1 tablete -
V/NRP/07/1686-07 100 mg 180 Polietilēna pudelīte, 1 tablete -
Lodisure 1 mg V/DCP/20/0052 Dechra Regulatory B.V., Nīderlande QC08CA01 cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Amlodipine
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (28-Oct-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (28-Oct-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_L (28-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/20/0052-01 1 mg 2 Blisteris, 14 tablete -
V/DCP/20/0052-02 1 mg 4 Blisteris, 14 tablete -
V/DCP/20/0052-03 1 mg 6 Blisteris, 14 tablete -
V/DCP/20/0052-04 1 mg 12 Blisteris, 14 tablete -
Genestran 75 µg/ml V/MRP/11/0068 aniMedica GmbH, Vācija QG02AD90 cattle; pigs; horses Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Cloprostenol sodium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release aniMedica GmbH, Vācija;Industrial Veterinaria, S.A., Spānija
Date of authorisation/renewal: 30-Nov-2016
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Sep-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Sep-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (09-Feb-2026)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/11/0068-01 75 µg/ml 1 Pudelīte (caurspīdīga), 20 ml -
V/MRP/11/0068-02 75 µg/ml 5 Pudelīte (caurspīdīga), 20 ml -
V/MRP/11/0068-03 75 µg/ml 1 Pudelīte (caurspīdīga), 50 ml -
Insistor 10 mg/ml V/DCP/18/0029 VetViva Richter GmbH , Austrija QN02AC90 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Methadone hydrochloride
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Richter Pharma AG, Austrija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (21-May-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (21-May-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (21-May-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/18/0029-01 10 mg/ml 1 Stikla flakons ar alumīnija vāciņu, 5 ml -
V/DCP/18/0029-02 10 mg/ml 5 Stikla flakons ar alumīnija vāciņu, 5 ml -
V/DCP/18/0029-03 10 mg/ml 1 Stikla flakons ar alumīnija vāciņu, 10 ml -
V/DCP/18/0029-04 10 mg/ml 5 Stikla flakons ar alumīnija vāciņu, 10 ml -
V/DCP/18/0029-05 10 mg/ml 1 Stikla flakons ar alumīnija/plastmasas vāciņu, 5 ml -
V/DCP/18/0029-06 10 mg/ml 5 Stikla flakons ar alumīnija/plastmasas vāciņu, 5 ml -
V/DCP/18/0029-07 10 mg/ml 1 Stikla flakons ar alumīnija/plastmasas vāciņu, 10 ml -
V/DCP/18/0029-08 10 mg/ml 5 Stikla flakons ar alumīnija/plastmasas vāciņu, 10 ml -

3081 record

© Food and veterinary service · 2026 Cookies policy